Copyright
©The Author(s) 2004.
World J Gastroenterol. Jan 15, 2004; 10(2): 186-189
Published online Jan 15, 2004. doi: 10.3748/wjg.v10.i2.186
Published online Jan 15, 2004. doi: 10.3748/wjg.v10.i2.186
Math 1 Math(A1).
Figure 1 Human 0.
3 kb AFP promoter.
Figure 2 Plasmid pshuttle and PCR product doubly-digested with MluI/NheI.
M: marker, 1: the PCR product of 99-744 re-gion of pshuttle, 2: the product of PCR doubly digested with MluI/NheI, 3: pshuttle, 4: doubly-digested pshuttle with MluI/ NheI, a 670 bp fragment was released from pshuttle.
Figure 3 A: Transcription levels of EGFP shown by Northern blot in three different cell lines, B: Transcription levels of EGFP gene detected by semi-quantity analysis in three cell lines.
Lane 1, HeLa cell; lane 2, HepG2 cell; lane 3, LO2 cell.
Figure 4 Expression of EGFP mRNA in HepG2 cells (A) and LO2 cells (B) ×200.
- Citation: Shi YJ, Gong JP, Liu CA, Li XH, Mei Y, Mi C, Huo YY. Construction of a targeting adenoviral vector carrying AFP promoter for expressing EGFP gene in AFP producing hepatocarcinoma cell. World J Gastroenterol 2004; 10(2): 186-189
- URL: https://www.wjgnet.com/1007-9327/full/v10/i2/186.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i2.186